Fatigue and cancer: causes, prevalence and treatment approaches
作者： L I Wagner , D Cella
关键词:
摘要: Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact on patients' functional ability quality of life. Hypotheses regarding aetiology fatigue are discussed, clinical practice guidelines for evaluation management oncology patients with reviewed. Both nonpharmacologic pharmacologic strategies summarised.
nature.com
sci-hub.se 参考文章(47)
Razelle Kurzrock, The role of cytokines in cancer‐related fatigue Cancer. ,vol. 92, pp. 1684- 1688 ,(2001) , 10.1002/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z
Eduardo Bruera, Karen Macmillan, Norma Kuehn, John Hanson, R. Neil MacDonald, A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer Cancer. ,vol. 66, pp. 1279- 1282 ,(1990) , 10.1002/1097-0142(19900915)66:6<1279::AID-CNCR2820660630>3.0.CO;2-R
Fernando C. Dimeo, Rolf-Dieter Stieglitz, Ulrike Novelli-Fischer, Sebastian Fetscher, Joseph Keul, Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer. ,vol. 85, pp. 2273- 2277 ,(1999) , 10.1002/(SICI)1097-0142(19990515)85:10<2273::AID-CNCR24>3.0.CO;2-B
K W Rammohan, Efficacy and safety of modafinil (Provigil(R)) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study Journal of Neurology, Neurosurgery & Psychiatry. ,vol. 72, pp. 179- 183 ,(2002) , 10.1136/JNNP.72.2.179
Gregory Curt, Patrick G. Johnston, Cancer fatigue: the way forward. Oncologist. ,vol. 8, pp. 27- 30 ,(2003) , 10.1634/THEONCOLOGIST.8-SUPPL_1-27
Anna L. Schwartz, John A. Thompson, Nehal Masood, Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncology Nursing Forum. ,vol. 29, pp. 1045- 1045 ,(2002) , 10.1188/02.ONF.E85-E90
Ian J Sadler, Paul B Jacobsen, Margaret Booth-Jones, Heather Belanger, Michael A Weitzner, Karen K Fields, Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. Journal of Pain and Symptom Management. ,vol. 23, pp. 406- 416 ,(2002) , 10.1016/S0885-3924(02)00388-3
Eduardo Bruera, Larry Driver, Elizabeth A. Barnes, Jie Willey, Loren Shen, J. Lynn Palmer, Carmelita Escalante, Patient-Controlled Methylphenidate for the Management of Fatigue in Patients With Advanced Cancer: A Preliminary Report Journal of Clinical Oncology. ,vol. 21, pp. 4439- 4443 ,(2003) , 10.1200/JCO.2003.06.156
Gary R. Morrow, Jane T. Hickok, Joseph A. Roscoe, Richard F. Raubertas, Paul L.R. Andrews, Patrick J. Flynn, Harry E. Hynes, Tarit K. Banerjee, Jeffrey J. Kirshner, David K. King, Differential Effects of Paroxetine on Fatigue and Depression: A Randomized, Double-Blind Trial From the University of Rochester Cancer Center Community Clinical Oncology Program Journal of Clinical Oncology. ,vol. 21, pp. 4635- 4641 ,(2003) , 10.1200/JCO.2003.04.070
Gregory A. Curt, William Breitbart, David Cella, Jerome E. Groopman, Sandra J. Horning, Loretta M. Itri, David H. Johnson, Christine Miaskowski, Susan L. Scherr, Russell K. Portenoy, Nicholas J. Vogelzang, Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition Oncologist. ,vol. 5, pp. 353- 360 ,(2000) , 10.1634/THEONCOLOGIST.5-5-353